Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CB-PRP in Retinitis Pigmentosa and Dry AMD
NCT04636853Phase 3Completed
- Sponsor
- Policlinico Gemelli
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of umbilical cord blood platelet-rich plasma in retinitis pigmentosa (RP), age-related macular degeneration (AMD), sponsored by Policlinico Gemelli. Started Dec 2020; status: completed.
02
Drugs
umbilical cord blood platelet-rich plasma
03
Conditions
retinitis pigmentosa (RP)age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT04636853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04636853.